Insights Into Chronic Lymphocytic Leukemia (CLL) – ASH Edition 2021
Perspectives of community physicians from across the US on the management of newly diagnosed and relapsed/refractory CLL
ASH EDITION January 12, 2021
Faculty Chair
Javier Pinilla, MD, PhD
Moffitt Cancer Center, Tampa, FL, US
REPORT TOPICS INCLUDE
- A roundtable discussion, moderated by an Axess Oncology Network physician, focusing on treatment of CLL was held on January 12, 2021, in a virtual setting
- Disease state and data presentations were developed by Javier Pinilla, MD, PhD, a medical expert from Moffitt Cancer Center, Tampa, Florida
- Insights were discussed on the following topics
- First-line treatment of CLL
- Treatment of relapsed/refractory CLL
GEOGRAPHIC REPRESENTATION AND CONTENT DEVELOPMENT
- Data collected via audience response system questioning and in-depth moderated discussion
- The group of advisors comprised community oncologists representative for the United States
